ilaprazole has been researched along with mosapride in 1 studies
| Studies (ilaprazole) | Trials (ilaprazole) | Recent Studies (post-2010) (ilaprazole) | Studies (mosapride) | Trials (mosapride) | Recent Studies (post-2010) (mosapride) |
|---|---|---|---|---|---|
| 53 | 24 | 42 | 286 | 90 | 142 |
| Protein | Taxonomy | ilaprazole (IC50) | mosapride (IC50) |
|---|---|---|---|
| hepatocyte nuclear factor 4-alpha isoform 2 | Homo sapiens (human) | 4.18 | |
| perilipin-5 | Homo sapiens (human) | 1.315 | |
| perilipin-1 | Homo sapiens (human) | 1.196 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 1.2753 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.3966 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.4 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.7 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.6794 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 1 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.908 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.3966 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.8117 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 1 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.2959 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.7932 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.3056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JW; Koo, BS; Lee, SH; Park, HS; Park, KW; Yoon, YH | 1 |
1 trial(s) available for ilaprazole and mosapride
| Article | Year |
|---|---|
Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzamides; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Morpholines; Prospective Studies; Proton Pump Inhibitors; Republic of Korea | 2019 |